- Description
- Benefits
- Risks
- Additional information
- Research
Description
PEG-MGF (Pegylated Mechano Growth Factor) is a modified analogue of IGF-1 splice variant MGF, designed for extended stability and prolonged activity in research environments. It is widely studied for its role in cellular repair, tissue regeneration, and growth factor signalling pathways.
MGF is naturally expressed in response to mechanical stress and tissue damage, particularly in muscle tissue. The PEG (polyethylene glycol) modification enhances the peptide’s half-life and stability, making PEG-MGF suitable for extended-duration experimental studies.
In controlled laboratory settings, PEG-MGF is investigated for its interaction with cellular repair mechanisms, satellite cell activation, and growth factor signalling pathways, particularly in relation to tissue regeneration and recovery processes.
Across Ireland and Europe, PEG-MGF is commonly studied in areas such as:
- Cellular repair and tissue regeneration research
- Growth factor signalling pathways (IGF-related)
- Muscle cell and satellite cell activation models
- Recovery and adaptation to mechanical stress
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – PEG-MGF
| Specification | Details |
|---|---|
| Product Name | PEG-MGF (Pegylated Mechano Growth Factor) |
| Compound Type | Modified IGF-1 splice variant peptide |
| Functional Class | Growth factor and regenerative peptide |
| Mechanism of Action | Activates repair pathways and growth factor signalling |
| Modification | PEGylation for extended stability and half-life |
| Biological Targets | Muscle tissue, satellite cells, growth factor pathways |
| Format | Lyophilised powder |
| Purity | Research-grade (high purity) |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Researched Benefits & Focus Areas – PEG-MGF
1. Tissue Repair & Regeneration Research
PEG-MGF has been studied for:
- Activation of cellular repair pathways
- Investigation of tissue regeneration mechanisms
- Role in recovery from mechanical stress in experimental models
Reference basis: Derived from preclinical research examining MGF and IGF-related peptides in tissue repair and regeneration.
2. Satellite Cell Activation & Muscle Research
Research has explored:
- Activation of satellite cells (muscle stem cells)
- Role in muscle tissue adaptation and repair
- Influence on cellular growth signalling pathways
Reference basis: Based on studies investigating MGF’s role in muscle biology and cellular regeneration.
3. Extended Activity via PEGylation
PEG-MGF is modified to:
- Increase stability and half-life in research models
- Allow for prolonged biological activity
- Support extended-duration experimental studies
Reference basis: Supported by pharmacological research into peptide PEGylation and stability enhancement.
4. Growth Factor Signalling Research
- Studied for interaction with IGF-related signalling pathways
- Explored in cellular growth and repair models
- Investigated for response to mechanical and cellular stress
Reference basis: Derived from research into IGF-1 splice variants and growth factor signalling mechanisms.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – PEG-MGF
1. Uncontrolled Cellular Proliferation
- May stimulate cell growth pathways broadly
- Potential for unregulated proliferation in experimental models
Reference basis: Based on research into IGF-related signalling and cellular growth mechanisms.
2. Extended Activity Considerations
- Prolonged half-life may lead to extended biological effects
- Requires careful experimental control
Reference basis: Derived from studies on PEGylated peptide pharmacokinetics.
3. Off-Target Biological Effects
- Possible interaction with multiple tissues and signalling pathways
- Broad systemic influence in experimental conditions
Reference basis: Based on research into growth factor signalling across biological systems.
4. Limited Long-Term Research
- Lack of extensive long-term data
- Primarily studied in preclinical environments
Reference basis: Reflects the current stage of PEG-MGF research.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
Related Products
ARA-290 16mg
BPC-157 5mg
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS